Sihuan Pharma and Covance Strike Global CRO Partnership Deal

Sihuan Pharma formed a long-term partnership with Covance Labs, a global US-headquartered CRO, under which Covance will provide Sihuan with expertise to coordinate international and China filings of novel drugs in its development portfolio. Covance said its standardized global systems will promote a more efficient pathway for Sihuan, allowing the company to bring its products to multiple markets more quickly. More details.... Stock Symbol: (HK: 0460) Share this with colleagues: // //